Pfizer Has A Head Start, But The Covid-19 Vaccine Market Is Still Up For Grabs

Any first-mover advantage won’t last long, as some vaccine candidates may be easier to transport and administer than others.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive